Atlas Trials

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Clinical trial NCT06480461 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06480461
Sponsor
Shanghai Vitalgen BioPharma Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2024-09-02
Primary completion
2026-09-10
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.